Innovating Works

IMM

Desconocido
T-OP: Training Network for Optimizing Adoptive T cell Therapy of Cancer INSTIL BIO UK LIMITED participó en un H2020: H2020-MSCA-ITN-2020 Over the last years, immunotherapy – using a patient’s own immune system to fight tumours – has emerged as an important complement to standa...
2020-08-27 - 2025-02-28 | Financiado
EN_ACTI2NG: European Network on Anti Cancer Immuno Therapy Improvement by modification of CAR and TCR Interactio... INSTIL BIO UK LIMITED participó en un H2020: H2020-MSCA-ITN-2016 The EN-ACTI2NG program (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale...
2016-08-31 - 2021-04-30 | Financiado
ATTACK: Adoptive engineered T cell Trials to Achieve Cancer Killing INSTIL BIO UK LIMITED participó en un FP7: The aim of this research is to exploit technology for nucleic acid delivery through the clinical testing of adoptive engineered T cells to t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.